Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (351-360 of 682) with videos related to

Pageof 69
Sort By:
The Journal of Urology|January 27, 2021
Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical TrialsRana R McKay, Jacob Berchuck, Lucia Kwak, et al.
Cancer|August 9, 2025
Optimizing treatment for metastatic castration-resistant prostate cancer: Food and Drug Administration-approved therapies, emerging strategies, and biomarker-driven approachesFaisal Saeed, Jacob E Berchuck, Mehmet Asim Bilen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 26, 2020
Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practicesCatherine H Watson, Lindsay Soo, Brittany A Davidson, et al.
Neoplasia (New York, N.Y.)|July 7, 2024
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, CanadaParamdeep Kaur, Andrew Berchuck, Anne Chase, et al.
Gynecologic Oncology|August 12, 2015
Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinomaSharareh Siamakpour-Reihani, Kouros Owzar, Chen Jiang, et al.
Cancer|August 28, 2019
Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancerLaura J Havrilesky, Jui-Chen Yang, Paula S Lee, et al.
Cell Reports|June 29, 2022
G6PD inhibition sensitizes ovarian cancer cells to oxidative stress in the metastatic omental microenvironmentShree Bose, Qiang Huang, Yunhan Ma, et al.
Gynecologic Oncology|October 24, 2007
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositionsJohnathan M Lancaster, C Bethan Powell, Noah D Kauff, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1996
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cellsJ P Vaughn, P L Davis, M D Jarboe, et al.
Ophthalmology. Glaucoma|July 30, 2020
Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCTAtalie C Thompson, Alessandro A Jammal, Samuel I Berchuck, et al.
Pageof 69

Showing results (351-360 of 682) with videos related to

Sort By:
Pageof 69
The Journal of Urology|January 27, 2021
Outcomes of Post-Neoadjuvant Intense Hormone Therapy and Surgery for High Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical TrialsRana R McKay, Jacob Berchuck, Lucia Kwak, et al.
Cancer|August 9, 2025
Optimizing treatment for metastatic castration-resistant prostate cancer: Food and Drug Administration-approved therapies, emerging strategies, and biomarker-driven approachesFaisal Saeed, Jacob E Berchuck, Mehmet Asim Bilen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 26, 2020
Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practicesCatherine H Watson, Lindsay Soo, Brittany A Davidson, et al.
Neoplasia (New York, N.Y.)|July 7, 2024
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, CanadaParamdeep Kaur, Andrew Berchuck, Anne Chase, et al.
Gynecologic Oncology|August 12, 2015
Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinomaSharareh Siamakpour-Reihani, Kouros Owzar, Chen Jiang, et al.
Cancer|August 28, 2019
Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancerLaura J Havrilesky, Jui-Chen Yang, Paula S Lee, et al.
Cell Reports|June 29, 2022
G6PD inhibition sensitizes ovarian cancer cells to oxidative stress in the metastatic omental microenvironmentShree Bose, Qiang Huang, Yunhan Ma, et al.
Gynecologic Oncology|October 24, 2007
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositionsJohnathan M Lancaster, C Bethan Powell, Noah D Kauff, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1996
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cellsJ P Vaughn, P L Davis, M D Jarboe, et al.
Ophthalmology. Glaucoma|July 30, 2020
Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCTAtalie C Thompson, Alessandro A Jammal, Samuel I Berchuck, et al.
Pageof 69